Peter Young, president and chief executive officer of AlphaVax, is the new chairman of the board for the North Carolina Biosciences Organization.

Sam Taylor is the new president of the group. He formerly served as executive vice president.

“NCBIO is a strong voice for the life science industry in North Carolina and a significant factor in maintaining North Carolina’s position as one of the premier biotechnology regions in the country,” Young said in a statement. “I am looking forward to working with our member companies to help build an even stronger bioscience industry in North Carolina.

“NCBIO has been a strong advocate for the impact this critical industry can exert on North Carolina’s economic future, and plays a key role with the state’s decision-makers,” Young added. “We plan to expand that role in the coming year and strengthen the life science network across North Carolina.”

Three vice chairmen were also named for NCBIO’s board: J. Donald deBethizy, president, Targacept; Ken Lee, general partner of Hatteras Biocapital; and Eric Ward, CEO, CropSolution. Tim Gupton, a partner at Hughes Pittman & Gupton, was re-elected Treasurer of the Organization, and Brenda Summers was elected Secretary.

NCBIO includes more than 100 companies and institutions.